Skip to content
Open access

Neuroprotective Role of E3 Ubiquitin Ligase TRIM2 in Parkinson's Disease: Attenuation of Oxidative Stress and Apoptosis via Promoting ELAVL1 Ubiquitination

Aug 2026 · CNS Neuroscience & Therapeutics · Vol 32 · 0 citations · 57 references
Medicine

TL;DR

A downregulated TRIM2 is identified in the substantia nigra pars compacta of PD rats based on label‐free proteomics, and the impact of TRIM2 on PD is unknown.

Abstract

Parkinson's disease (PD) is characterized by the progressive loss of dopaminergic neurons, where oxidative stress and neuronal apoptosis are key pathogenic events. In this study, we identified a downregulated TRIM2 in the substantia nigra pars compacta (SNc) of PD rats based on label‐free proteomics. However, the impact of TRIM2 on PD is unknown.

Read PDF

Similar papers

Sep 2026

Targeting CH25H restores p62-mediated α-synuclein clearance.

Astrocytes remove extracellular α-synuclein aggregates through p62-dependent autophagy, yet the factors limiting this defense remain unclear. Zhang and colleagues recently identified cholesterol 25-hydroxylase as an inducible negative regulator of p62-mediated clearance. Genetic suppression or a p62-derived decoy pepti...

G. S. Dawe · 0 citations
Open access Sep 2026

RETRACTED: Atiq et al. Vitamin E Analog Trolox Attenuates MPTP-Induced Parkinson’s Disease in Mice, Mitigating Oxidative Stress, Neuroinflammation, and Motor Impairment. Int. J. Mol. Sci. 2023, 24, 9942

The Journal retracts the article "Vitamin E Analog Trolox Attenuates MPTP-Induced Parkinson's Disease in Mice, Mitigating Oxidative Stress, Neuroinflammation, and Motor Impairment" [...].

Abubakar Atiq, Hyeon Jin Lee, Amjad Khan et al. · 0 citations
Review Open access Sep 2026

NAD+ signaling in Parkinson's disease: molecular mechanisms and therapeutic perspectives

Parkinson's disease (PD) is the second most prevalent neurodegenerative disorder worldwide, characterized by the progressive loss of dopaminergic neurons in the substantia nigra, accumulation of α-synuclein (α-syn), mitochondrial dysfunction, and neuroinflammation. Nicotinamide adenine dinucleotide (NAD + ), a cruc...

Tian-Bao Wang, Xue Zhou, Xin-Hua Chen · 0 citations
Open access Sep 2026

Acteoside alleviates Parkinson's disease-associated neurodegeneration and oxidative stress via an m6A-dependent Nrf2 regulatory axis.

Acteoside (ACT), a compound extracted from Cistanche tubulosa, was found to exert neuroprotective effects in dopaminergic neurons and improved the synucleinopathy in a mouse PD model, providing evidence that ACT could be a potential therapeutic agent for PD.

Ya-Tan Li, Yu-Jie Zeng, Q. Luo et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.